Covington & Burling advised AbbVie on the transaction, and Fenwick & West advised Aliada Therapeutics. AbbVie (NYSE: ABBV), a pharmaceutical firm, announced it has entered into...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Insightly in the transaction. Insightly, an all-in-one provider of customer relationship management (CRM), marketing automation and customer success software, announced its merger...
You must be a Standard 1 Year member to access this content.
Fenwick & West is advising Escient Pharmaceuticals on the transaction, and Covington & Burling is advising Incyte. Incyte (Nasdaq:INCY) announced the acquisition of Escient Pharmaceuticals (“Escient”). Incyte...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Wiz in the transaction. Wiz, a developer of a cloud security platform designed to help businesses secure their infrastructure at scale, announced...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis is representing Vista Equity Partners in the transaction, and Fenwick & West is representing Model N. Vista Equity Partners, which announced its definitive...
You must be a Standard 1 Year member to access this content.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Standard BioTools Inc. on the transaction, and Fenwick & West advised SomaLogic, Inc. Standard BioTools Inc. (Nasdaq: LAB) and SomaLogic (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP is representing CISCO Systems, Inc. in the transaction. A worldwide leader in technology, CISCO Systems, Inc. (NASDAQ: CSCO) announced its acquisition of Oort,...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP is representing Cisco in the transaction. Fenwick is representing CISCO Systems, Inc. (NASDAQ: CSCO), announced its pending acquisition of Accedian, a network...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP represented DICE Therapeutics, Inc. in the transaction, while Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY)...
You must be a Standard 1 Year member to access this content.
Fenwick advised Neosec on the deal. Neosec, an API detection and response platform based on data and behavioral analytics, announced its acquisition by Akamai Technologies, Inc. (NASDAQ:...
You must be a Standard 1 Year member to access this content.
Fenwick advised Cisco Systems, Inc. on the deal. Cisco Systems, Inc. (NASDAQ: CSCO), a worldwide leader in technology, announced its pending acquisition of Valtix, a privately...
You must be a Standard 1 Year member to access this content.
Fenwick represented Jam City on the deal. Jam City, a mobile entertainment company, announced its spin-off of Plai Labs, a new social platform. In conjunction, the company...
You must be a Standard 1 Year member to access this content.
